RESEARCH PAPER
Thyroid cancer among silesia females population
| 1 | Zakład Epidemiologii i Śląski Rejestr Nowotworów Centrum Onkologii – Instytut im. M. Skłodowskiej-Curie, Oddział w Gliwicach
Kierownik Zakładu: Prof. dr hab. n. med. Brunon Zemła |
CORRESPONDING AUTHOR
Brunon Zemła
Brunon Zemła Zakład Epidemiologii i Śląski Rejestr Nowotworów Centrum Onkologii – Instytut im. M. Skłodowskiej-Curie Oddział w Gliwicach ul. Wybrzeże Armii Krajowej 15 44-101 Gliwice Tel./fax + 4832 278 97 03, tel. +48 601 068 763
Brunon Zemła Zakład Epidemiologii i Śląski Rejestr Nowotworów Centrum Onkologii – Instytut im. M. Skłodowskiej-Curie Oddział w Gliwicach ul. Wybrzeże Armii Krajowej 15 44-101 Gliwice Tel./fax + 4832 278 97 03, tel. +48 601 068 763
Med Srod. 2011;14(2):39–44
KEYWORDS
ABSTRACT
Background:
During the past several decades an increasing incidence of thyroid cancer has been reported especially among women in very many parts of the world including Silesia Voivodeship.
Material and Methods:
Based on thyroid cancer data (and demographic data) following incidence rates were estimated: age-specific rates (for 5-year age groups, ie. 0–4, 5–9, etc. up until the age of 85+, crude rates (for all ages) and age standardized rates (ASR) – with the application of M. Spiegelman’s direct method as well as age structure of “world population “ for direct comparison.
Results:
Thyroid cancer age-adjusted rates (ASR) among Silesia females have increased by about 20% from 1999 to 2008. The incidence of thyroid cancer has been estimated taking into account histopathological types (carcinoma papillare, carcinoma folliculare and others) and time-trends according to age groups (20–44 years of age, 45–59 years of age and ‡60 years of age).
Conclusions:
The observation is being made of distinct increase of thyroid papilloma cancer and other types of cancer particularly among young women.
During the past several decades an increasing incidence of thyroid cancer has been reported especially among women in very many parts of the world including Silesia Voivodeship.
Material and Methods:
Based on thyroid cancer data (and demographic data) following incidence rates were estimated: age-specific rates (for 5-year age groups, ie. 0–4, 5–9, etc. up until the age of 85+, crude rates (for all ages) and age standardized rates (ASR) – with the application of M. Spiegelman’s direct method as well as age structure of “world population “ for direct comparison.
Results:
Thyroid cancer age-adjusted rates (ASR) among Silesia females have increased by about 20% from 1999 to 2008. The incidence of thyroid cancer has been estimated taking into account histopathological types (carcinoma papillare, carcinoma folliculare and others) and time-trends according to age groups (20–44 years of age, 45–59 years of age and ‡60 years of age).
Conclusions:
The observation is being made of distinct increase of thyroid papilloma cancer and other types of cancer particularly among young women.
REFERENCES (9)
1.
Kilfoy B.A., Zheng T., Holford T.R., i wsp.: International patterns and trends in thyroid cancer incidence, 1973-2002. C. Causes Control 2009; 20: 525-531.
2.
Michalik B., Kern-Bałata J., Kukulska A., i wsp.: Has differentiated thyroid cancer (DTC) staging changed within the last ten years in the Silesia region of Poland? Pol. J. Endocrinol. 2010; 61 (5): 1-5.
3.
Roszkowska H., Goryński P.: Thyroid cancer in Poland in 1980-2000. Epidemiol. Rev. 2004; 58 (2): 369-376.
4.
Zemła B.: Zagrożenie rakiem tarczycy na Górnym Śląsku. Endokrynol. Pol. (supl.), 1995; 3(46): 153-163.
5.
Zemla B., Sowa J.: Raki tarczycy (brodawkowaty, p´cherzykowy, anaplastyczny i rdzeniasty) w populacjach kobiet miast i wsi na Górnym Âlàsku, wraz z próbà oceny ich tła etiologicznego. Nowotwory 1999; 49(3): 267-274.
6.
Steliarova-Foucher E., Stiller C.A., Pukkala E., i wsp.: Thyroid cancer incidence and survival among European children and adolescents (1978-1997): report from the Automated Childhood Cancer Information System project. Eur. J. Cancer 2006; 42(13): 2150-2169.
7.
Szybiński Z.: Rak tarczycy – problem epidemiologiczny i diagnostyczny. Endokrynol. Pol. 1990; 41:1365-1368.
8.
Tronko M.D., Howe G.R., Bogdanowa T.I., i wsp.: J. Natl. Cancer Inst. 2006; 5, 98(13): 897-903.
9.
Reynolds R.M., Weir J., Stockton D.L., i wsp.: Changing trends in incidence and mortality of thyroid cancer in Scotland. Clin. Endocrinol. (Oxf) 2005; 62(2): 156-162.
